An Observational Study of Continuous Oral Dosing of an Irreversible CYP17 Inhibitor, Abiraterone Acetate (CB7630), in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma
收藏DataCite Commons2025-09-02 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00005176/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of this study is to investigate the effect of abiraterone acetate on levels of androgens and steroid metabolites in bone marrow plasma of patients with metastatic castration-resistant prostate cancer (CRPC).
提供机构:
Vivli
创建时间:
2020-02-04



